Evidence-Based Risk Management: How Can we Succeed?: Deliberations from a Risk Management Advisory Council

Drug Information Journal

Volumn 37, Issue 1, 2003, Pages 127-134

  Perfetto, Eleanor M ^a   Ellison, Russell ^b   Ackermann, Susan ^c   Sherr, Marjorie ^d   Zaugg, Ana Maria ^d  

^a Weinberg Group Inc   (United States)

^b Sanofi Synthelabo Inc   (United Kingdom)

^c Hoffmann La Roche Ltd   (United States)

^d IQVIA   (United States)

Author keywords

Databases; Evidence based medicine; Medical error; Prescribing; Risk management

Indexed keywords

ARTICLE; DATA BASE; DRUG INDUSTRY; DRUG SAFETY; ERROR; FOOD AND DRUG ADMINISTRATION; HEALTH CARE QUALITY; PRESCRIPTION; PRIORITY JOURNAL; RISK MANAGEMENT;

EID: 0142246385     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286150303700115     Document Type: Article

References (8)

1. Anonymous. Office of Drug Safety Annual Report. Center for Drug Evaluation and Research 2001. www.fda.gov/cder/Offices/ODS/annrep2001/an nualreport2001.htm. (Accessed on 09/27/02.)
2. Hubbard WK. Drug Safety and Risk Management; Notice of Meeting. Federal Register. 2002 July 11;63 (133).
3. US Department of Health and Human Services. PDUFA Reauthorization Good For American Patients. HHS News. June 18, 2002.
4. Butler, Mary Ellen. Congress Reauthorizes PDUFA. US Medicine Institute for Health Studies. July: 1, 2002.
5. Centers for Education and Research on Therapeutics. Overview: Fact Sheet. www.ahcpr. gov/clinic/certsovr.htm. (Accessed on 10/01/02)
6. Duke Center for Education and Research on Therapeutics. Duke CERTs Program. http://www. dcri.duke.edu/research/fields/certs/index.html. (Accessed on 09/27/02)
7. US Food and Drug Administration. Accutane Risk Management Program Strengthened. FDA Consumer. 2002;36(1).
8. US Department of Health and Human Services. FDA Approves Restricted Marketing of Lotronex. FDA News. June 7, 2002.